127 related articles for article (PubMed ID: 2099226)
1. A screening test for modified hemoglobin blood substitutes before clinical use: based on C3a complement activation in human plasma.
Chang TM; Lister C
Biomater Artif Cells Artif Organs; 1990; 18(5):693-701. PubMed ID: 2099226
[TBL] [Abstract][Full Text] [Related]
2. A preclinical screening test for modified hemoglobin to bridge the gap between animal safety studies and use in human.
Chang TM; Lister C
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):565-73. PubMed ID: 1391479
[TBL] [Abstract][Full Text] [Related]
3. Effects of homologous and heterologous stroma-free hemoglobin and polyhemoglobin on complement activation, leucocytes and platelets.
Ning J; Chang TM
Biomater Artif Cells Artif Organs; 1990; 18(2):219-32. PubMed ID: 2369648
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.
Williams JJ; Yellin SA; Slotman GJ
Arch Surg; 1986 Mar; 121(3):305-7. PubMed ID: 3484946
[TBL] [Abstract][Full Text] [Related]
5. Use of finger-prick human blood samples as a more convenient way for in-vitro screening of modified hemoglobin blood substitutes for complement activation: a preliminary report.
Chang TM; Lister CW
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):685-90. PubMed ID: 8117858
[TBL] [Abstract][Full Text] [Related]
6. Assessment of blood substitutes: II. In-vitro complement activation of human plasma and blood for safety studies in research, development, industrial production and preclinical analysis.
Chang TM; Lister CW
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):171-80. PubMed ID: 8087240
[TBL] [Abstract][Full Text] [Related]
7. Complement activation and the toxicity of stroma-free hemoglobin solutions in primates.
Feola M; Simoni J; Dobke M; Canizaro PC
Circ Shock; 1988 Aug; 25(4):275-90. PubMed ID: 3168173
[TBL] [Abstract][Full Text] [Related]
8. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of the storage conditions for blood samples which are used for determination of complement activation.
Stöve S; Klos A; Bautsch W; Köhl J
J Immunol Methods; 1995 May; 182(1):1-5. PubMed ID: 7769237
[TBL] [Abstract][Full Text] [Related]
10. Assays for plasma complement activation by x-ray contrast media.
Eaton S; Tsay HM; Yost F; Tweedle MF
Invest Radiol; 1990 Jul; 25(7):789-92. PubMed ID: 2391195
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation.
Pfeifer PH; Kawahara MS; Hugli TE
Clin Chem; 1999 Aug; 45(8 Pt 1):1190-9. PubMed ID: 10430784
[TBL] [Abstract][Full Text] [Related]
12. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma.
Norda R; Schött U; Berséus O; Akerblom O; Nilsson B; Ekdahl KN; Stegmayr BG; Knutson F
Vox Sang; 2012 Feb; 102(2):125-33. PubMed ID: 21770955
[TBL] [Abstract][Full Text] [Related]
13. Complement activation by propofol and its effect during propofol anaesthesia.
Ohmizo H; Iwama H; Sugita T
Anaesth Intensive Care; 1999 Dec; 27(6):623-7. PubMed ID: 10631417
[TBL] [Abstract][Full Text] [Related]
14. Activation of the alternative complement pathway by intraocular lenses.
Mondino BJ; Nagata S; Glovsky MM
Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):905-8. PubMed ID: 4008203
[TBL] [Abstract][Full Text] [Related]
15. A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a.
Hack CE; Paardekooper J; Eerenberg AJ; Navis GO; Nijsten MW; Thijs LG; Nuijens JH
J Immunol Methods; 1988 Apr; 108(1-2):77-84. PubMed ID: 3258341
[TBL] [Abstract][Full Text] [Related]
16. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
[TBL] [Abstract][Full Text] [Related]
17. Effect of methylprednisolone, prednisolone and dexamethasone on granulocyte function and complement activation.
Redl H; Lamche H; Paul E; Schiesser A; Schlag G
Prog Clin Biol Res; 1987; 236B():261-72. PubMed ID: 2441413
[No Abstract] [Full Text] [Related]
18. Plasma C3a and C4a levels in liver transplant recipients: a longitudinal study.
Pfeifer PH; Brems JJ; Brunson M; Hugli TE
Immunopharmacology; 2000 Feb; 46(2):163-74. PubMed ID: 10647874
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of complement activation with EDTA in vivo during sham hemodialysis.
Kandus A; Benedik M; Bren AF; Drinovec J; Fliser D; Knap B; Kladnik S; Ivanovich P
Int J Artif Organs; 1991 Aug; 14(8):515-7. PubMed ID: 1937941
[TBL] [Abstract][Full Text] [Related]
20. Direct induction of complement activation by pharmacologic activation of plasminogen.
Schaiff WT; Eisenberg PR
Coron Artery Dis; 1997 Jan; 8(1):9-18. PubMed ID: 9101117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
